Protein clumps in the brain have long been associated with Alzheimer’s, but other potential causes of the condition are now ...

The first evidence that removing amyloid plaques may delay Alzheimer’s symptoms has now been published. In The Lancet Neurology on March 19, scientists led by Randall Bateman at Washington University ...

The EMA has recommended refusing marketing authorization for donanemab, a monoclonal antibody against amyloid beta, in the ...

A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have ...

If you’re in your 30s, 40s or 50s, dementia might feel like a distant concern, something you associate with advanced age.

Alzheimer’s disease is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like changes in sleep, anxiety and depression can be early signs of the disease.

Alzheimer's Disease (AD) is characterized by a host of recognizable cognitive symptoms, but many non-cognitive symptoms like ...

Research shows experimental anti-amyloid drug reduced cognitive symptom risk by 50% in people with rare genetic mutations ...

A clinical trial involving individuals genetically predisposed to develop early-onset Alzheimer’s disease suggests that ...

For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...

The brain's immune cells removed plaques and helped restore a healthier environment in the brains of immunized patients. For over 30 years, scientists have focused on treating Alzheimer’s disease by ...

What do you know about a study that says aerobics might be good for slowing down the progression of Alzheimer’s disease? I’ve ...